Litcius/Paper detail

Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease.

Chunsun Jiang, Tapasi Rana, Lee‐Way Jin, Susan A. Farr, John E. Morley, Hongwei Qin, Gang Liu, Rui-Ming Liu

2023PubMed21 citationsDOIOpen Access PDF

Abstract

-induced senescence, in primary mouse and human astrocytes. Treatment with the conditional medium (CM) from senescent astrocytes induced neuron apoptosis. Importantly, the PAI-1 deficient CM from senescent astrocytes that overexpress a secretion deficient PAI-1 (sdPAI-1) has significantly reduced effect on neurons, compared to the PAI-1 containing CM from senescent astrocytes overexpressing wild type PAI-1 (wtPAI-1), although sdPAI-1 and wtPAI-1 induce similar degree of astrocyte senescence. Together, our results suggest that increased PAI-1, intracellularly or extracellularly, may contribute to brain cell senescence in LOAD and that senescent astrocytes can induce neuron apoptosis through secreting pathologically active molecules, including PAI-1.

Topics & Concepts

SenescenceAstrocyteBiologyPlasminogen activator inhibitor-1Plasminogen activatorAlzheimer's diseaseCell biologyEndocrinologyNeuroscienceInternal medicineCentral nervous systemMedicineDiseaseTelomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsAntioxidant Activity and Oxidative Stress
Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease. | Litcius